143 related articles for article (PubMed ID: 37648580)
1. Automated Assessment of T2-Weighted MRI to Differentiate Malignant and Benign Primary Solid Liver Lesions in Noncirrhotic Livers Using Radiomics.
Starmans MPA; Miclea RL; Vilgrain V; Ronot M; Purcell Y; Verbeek J; Niessen WJ; Ijzermans JNM; de Man RA; Doukas M; Klein S; Thomeer MG
Acad Radiol; 2024 Mar; 31(3):870-879. PubMed ID: 37648580
[TBL] [Abstract][Full Text] [Related]
2. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of benign from malignant solid renal lesions with MRI-based radiomics and machine learning.
Massa'a RN; Stoeckl EM; Lubner MG; Smith D; Mao L; Shapiro DD; Abel EJ; Wentland AL
Abdom Radiol (NY); 2022 Aug; 47(8):2896-2904. PubMed ID: 35723716
[TBL] [Abstract][Full Text] [Related]
4. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
[TBL] [Abstract][Full Text] [Related]
5. Radiomics Based on Contrast-Enhanced MRI in Differentiation Between Fat-Poor Angiomyolipoma and Hepatocellular Carcinoma in Noncirrhotic Liver: A Multicenter Analysis.
Zhao X; Zhou Y; Zhang Y; Han L; Mao L; Yu Y; Li X; Zeng M; Wang M; Liu Z
Front Oncol; 2021; 11():744756. PubMed ID: 34722300
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study.
Han YE; Cho Y; Kim MJ; Park BJ; Sung DJ; Han NY; Sim KC; Park YS; Park BN
Abdom Radiol (NY); 2023 Jan; 48(1):244-256. PubMed ID: 36131163
[TBL] [Abstract][Full Text] [Related]
7. A Magnetic Resonance Imaging Radiomics Signature to Distinguish Benign From Malignant Orbital Lesions.
Duron L; Heraud A; Charbonneau F; Zmuda M; Savatovsky J; Fournier L; Lecler A
Invest Radiol; 2021 Mar; 56(3):173-180. PubMed ID: 32932375
[TBL] [Abstract][Full Text] [Related]
8. A Machine Learning-Based Unenhanced Radiomics Approach to Distinguishing Between Benign and Malignant Breast Lesions Using T2-Weighted and Diffusion-Weighted MRI.
Liu Y; Jia X; Zhao J; Peng Y; Yao X; Hu X; Cui J; Chen H; Chen X; Wu J; Hong N; Wang S; Wang Y
J Magn Reson Imaging; 2023 Nov; ():. PubMed ID: 37933890
[TBL] [Abstract][Full Text] [Related]
9. Machine learning-based radiomics model to predict benign and malignant PI-RADS v2.1 category 3 lesions: a retrospective multi-center study.
Jin P; Shen J; Yang L; Zhang J; Shen A; Bao J; Wang X
BMC Med Imaging; 2023 Mar; 23(1):47. PubMed ID: 36991347
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric MRI-Based Interpretable Radiomics Machine Learning Model Differentiates Medulloblastoma and Ependymoma in Children: A Two-Center Study.
Yimit Y; Yasin P; Tuersun A; Wang J; Wang X; Huang C; Abudoubari S; Chen X; Ibrahim I; Nijiati P; Wang Y; Zou X; Nijiati M
Acad Radiol; 2024 Mar; ():. PubMed ID: 38508934
[TBL] [Abstract][Full Text] [Related]
11. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
12. Value of MRI-based radiomics analysis for differentiation of benign and malignant epithelial neoplasms in the lacrimal gland: a retrospective study.
Guo J; Li Z; Qu X; Xian J
Acta Radiol; 2021 Jun; 62(6):743-751. PubMed ID: 32660315
[TBL] [Abstract][Full Text] [Related]
13. Machine learning-based multiparametric magnetic resonance imaging radiomics model for distinguishing central neurocytoma from glioma of lateral ventricle.
Mo H; Liang W; Huang Z; Li X; Xiao X; Liu H; He J; Xu Y; Wu Y
Eur Radiol; 2023 Jun; 33(6):4259-4269. PubMed ID: 36547672
[TBL] [Abstract][Full Text] [Related]
14. The Application Value of MRI T2
Huang F; Liu X; Liu P; Xu D; Li Z; Lin H; Xie A
Comput Math Methods Med; 2022; 2022():7099476. PubMed ID: 36203532
[TBL] [Abstract][Full Text] [Related]
15. Classification of pulmonary lesion based on multiparametric MRI: utility of radiomics and comparison of machine learning methods.
Wang X; Wan Q; Chen H; Li Y; Li X
Eur Radiol; 2020 Aug; 30(8):4595-4605. PubMed ID: 32222795
[TBL] [Abstract][Full Text] [Related]
16. Differentiating Benign from Malignant Renal Tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists.
Xu Q; Zhu Q; Liu H; Chang L; Duan S; Dou W; Li S; Ye J
J Magn Reson Imaging; 2022 Apr; 55(4):1251-1259. PubMed ID: 34462986
[TBL] [Abstract][Full Text] [Related]
17. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
[TBL] [Abstract][Full Text] [Related]
18. Whole-tumor 3D volumetric MRI-based radiomics approach for distinguishing between benign and malignant soft tissue tumors.
Fields BKK; Demirjian NL; Hwang DH; Varghese BA; Cen SY; Lei X; Desai B; Duddalwar V; Matcuk GR
Eur Radiol; 2021 Nov; 31(11):8522-8535. PubMed ID: 33893534
[TBL] [Abstract][Full Text] [Related]
19. Different multiparametric MRI-based radiomics models for differentiating stage IA endometrial cancer from benign endometrial lesions: A multicenter study.
Bi Q; Wang Y; Deng Y; Liu Y; Pan Y; Song Y; Wu Y; Wu K
Front Oncol; 2022; 12():939930. PubMed ID: 35992858
[TBL] [Abstract][Full Text] [Related]
20. T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study.
Wei M; Zhang Y; Bai G; Ding C; Xu H; Dai Y; Chen S; Wang H
Insights Imaging; 2022 Aug; 13(1):130. PubMed ID: 35943620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
